U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Abnormal circulating IgG concentration

MedGen UID:
1687987
Concept ID:
C5139422
Finding
Synonyms: Abnormal circulating IgG level; Abnormal IgG level in blood
 
HPO: HP:0410242

Definition

An abnormal deviation from normal levels of IgG immunoglobulin in blood. [from HPO]

Conditions with this feature

Ectodermal dysplasia and immunodeficiency 1
MedGen UID:
375787
Concept ID:
C1846008
Disease or Syndrome
Ectodermal dysplasia with immunodeficiency-1 (EDAID1) is an X-linked recessive disorder that characteristically affects only males. Affected individuals have onset of recurrent severe infections due to immunodeficiency in early infancy or in the first years of life. There is increased susceptibility to bacterial, pneumococcal, mycobacterial, and fungal infections. Laboratory studies usually show dysgammaglobulinemia with low IgG subsets and normal or increased IgA and IgM, consistent with impaired 'class-switching' of B cells, although immunologic abnormalities may be subtle compared to the clinical picture, and B- and T-cell numbers are usually normal. There is a poor antibody response to polysaccharide vaccinations, particularly pneumococcus; response to other vaccinations is variable. Patients also have features of ectodermal dysplasia, including conical incisors, hypo/anhidrosis, and thin skin or hair. Severely affected individuals may also show lymphedema, osteopetrosis, and, rarely, hematologic abnormalities. The phenotype is highly variable, likely due to different hypomorphic mutations, and may be fatal in childhood. Intravenous immunoglobulins and prophylactic antibiotics are used as treatment; some patients may benefit from bone marrow transplantation. Although only males tend to be affected with immunodeficiency, many patients inherit a mutation from a mother who has mild features of IP or conical teeth (summary by Doffinger et al., 2001, Orange et al., 2004, Roberts et al., 2010, Heller et al., 2020). Genetic Heterogeneity of Ectodermal Dysplasia and Immune Deficiency Also see EDAID2 (612132), caused by mutation in the NFKBIA gene (164008).
Immunodeficiency 18
MedGen UID:
816457
Concept ID:
C3810127
Disease or Syndrome
Immunodeficiency-18 is an autosomal recessive primary immunodeficiency characterized by onset in infancy or early childhood of recurrent infections. The severity is variable, encompassing both a mild immunodeficiency and severe combined immunodeficiency (SCID), resulting in early death without bone marrow transplantation in some patients. Immunologic work-up of the IMD18 SCID patients shows a T cell-negative, B cell-positive, natural killer (NK) cell-positive phenotype, whereas T-cell development is not impaired in the mild form of IMD18 (summary by de Saint Basile et al., 2004).
Immunodeficiency 32B
MedGen UID:
865178
Concept ID:
C4016741
Disease or Syndrome
Immunodeficiency-32B is an autosomal recessive primary immunodeficiency characterized by recurrent infections resulting from variable defects in immune cell development or function, including monocytes, dendritic cells, and natural killer (NK) cells. Patients have particular susceptibility to viral disease (summary by Mace et al., 2017).
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
MedGen UID:
904009
Concept ID:
C4225260
Disease or Syndrome
Immunodeficiency-44 (IMD44) is an autosomal recessive primary immunodeficiency characterized by increased susceptibility to viral infections and adverse multisystemic reaction to vaccination in some patients. Affected individuals appear to have defects in mitochondrial fission and fusion (summary by Shahni et al., 2015).
Autoinflammatory disease, systemic, with vasculitis
MedGen UID:
1841161
Concept ID:
C5830525
Disease or Syndrome
Systemic autoinflammatory disease with vasculitis (SAIDV) is an autosomal dominant disorder that manifests soon after birth with features such as purpuric skin rash, fever, hepatosplenomegaly, and elevated C-reactive protein (CRP; 123260). Laboratory studies may show leukocytosis, thrombocytopenia, and autoantibodies. A subset of patients develop progressive liver involvement that may result in fibrosis. Other systemic features, such as periorbital edema, conjunctivitis, infections, abdominal pain, and arthralgia are usually observed. Mutations occur de novo. De Jesus et al. (2023) referred to this disorder as LAVLI (LYN kinase-associated vasculopathy and liver fibrosis).

Professional guidelines

PubMed

Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P
Epilepsia 1991 Jan-Feb;32(1):122-7. doi: 10.1111/j.1528-1157.1991.tb05622.x. PMID: 1985820

Recent clinical studies

Etiology

Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K
Klin Onkol 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270. PMID: 30541309
Van Hemelrijck M, Karagiannis SN, Rohrmann S
Cancer Immunol Immunother 2017 Dec;66(12):1557-1562. Epub 2017 Aug 9 doi: 10.1007/s00262-017-2048-1. PMID: 28795218Free PMC Article
Shilova N, Huflejt ME, Vuskovic M, Obukhova P, Navakouski M, Khasbiullina N, Pazynina G, Galanina O, Bazhenov A, Bovin N
Top Curr Chem 2015;366:169-81. doi: 10.1007/128_2013_469. PMID: 24037491
Kwaan HC
Clin Hemorheol Microcirc 2013;55(1):75-83. doi: 10.3233/CH-131691. PMID: 23455837
De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R, Hooghe-Peters E
Eur J Endocrinol 2003 Sep;149(3):201-7. doi: 10.1530/eje.0.1490201. PMID: 12943522

Diagnosis

Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K
Klin Onkol 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270. PMID: 30541309
Van Hemelrijck M, Karagiannis SN, Rohrmann S
Cancer Immunol Immunother 2017 Dec;66(12):1557-1562. Epub 2017 Aug 9 doi: 10.1007/s00262-017-2048-1. PMID: 28795218Free PMC Article
Shilova N, Huflejt ME, Vuskovic M, Obukhova P, Navakouski M, Khasbiullina N, Pazynina G, Galanina O, Bazhenov A, Bovin N
Top Curr Chem 2015;366:169-81. doi: 10.1007/128_2013_469. PMID: 24037491
De Schepper J, Schiettecatte J, Velkeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdood P, Hooghe R, Hooghe-Peters E
Eur J Endocrinol 2003 Sep;149(3):201-7. doi: 10.1530/eje.0.1490201. PMID: 12943522
McIntyre JA, Wagenknecht DR, Faulk WP
Prog Lipid Res 2003 May;42(3):176-237. doi: 10.1016/s0163-7827(02)00048-6. PMID: 12689618

Therapy

Bossowski A, Urban M, Stasiak-Barmuta A
Pediatr Res 2003 Sep;54(3):425-9. Epub 2003 May 21 doi: 10.1203/01.PDR.0000076663.94850.44. PMID: 12761360
Mustafa MM, Buchanan GR, Winick NJ, McCracken GH, Tkaczewski I, Lipscomb M, Ansari Q, Agopian MS
J Pediatr Hematol Oncol 1998 Sep-Oct;20(5):451-7. doi: 10.1097/00043426-199809000-00008. PMID: 9787318
Barregård L, Eneström S, Ljunghusen O, Wieslander J, Hultman P
Int Arch Occup Environ Health 1997;70(2):101-6. doi: 10.1007/s004200050193. PMID: 9253638
Pacifici R, Paris L, Di Carlo S, Pichini S, Zuccaro P
Epilepsia 1991 Jan-Feb;32(1):122-7. doi: 10.1111/j.1528-1157.1991.tb05622.x. PMID: 1985820
Gleicher N, Harlow L
Mt Sinai J Med 1990 Sep;57(4):242-8. PMID: 2123297

Prognosis

Sun L, Li L, Sun T, Zhang L, Li C, Xu M, Hou Y, Peng J, Hou M, Wang L
Int Immunopharmacol 2021 Jun;95:107502. Epub 2021 Mar 6 doi: 10.1016/j.intimp.2021.107502. PMID: 33690000
Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K
Klin Onkol 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270. PMID: 30541309
Sarantopoulos S, Stevenson KE, Kim HT, Cutler CS, Bhuiya NS, Schowalter M, Ho VT, Alyea EP, Koreth J, Blazar BR, Soiffer RJ, Antin JH, Ritz J
Blood 2009 Apr 16;113(16):3865-74. Epub 2009 Jan 23 doi: 10.1182/blood-2008-09-177840. PMID: 19168788Free PMC Article
Goin JC, Venera G, Biscoglio de Jiménez Bonino M, Sterin-Borda L
Clin Exp Immunol 1997 Nov;110(2):219-25. doi: 10.1111/j.1365-2249.1997.tb08320.x. PMID: 9367405Free PMC Article
Marfaing-Koka A, Aubin JT, Grangeot-Keros L, Portier A, Benattar C, Merrien D, Agut H, Aucouturier P, Autran B, Wijdenes J
J Acquir Immune Defic Syndr Hum Retrovirol 1996 Jan 1;11(1):59-68. doi: 10.1097/00042560-199601010-00008. PMID: 8528734

Clinical prediction guides

Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K
Klin Onkol 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270. PMID: 30541309
Van Hemelrijck M, Karagiannis SN, Rohrmann S
Cancer Immunol Immunother 2017 Dec;66(12):1557-1562. Epub 2017 Aug 9 doi: 10.1007/s00262-017-2048-1. PMID: 28795218Free PMC Article
Shilova N, Huflejt ME, Vuskovic M, Obukhova P, Navakouski M, Khasbiullina N, Pazynina G, Galanina O, Bazhenov A, Bovin N
Top Curr Chem 2015;366:169-81. doi: 10.1007/128_2013_469. PMID: 24037491
McIntyre JA, Wagenknecht DR, Faulk WP
Prog Lipid Res 2003 May;42(3):176-237. doi: 10.1016/s0163-7827(02)00048-6. PMID: 12689618
Gleicher N, Harlow L
Mt Sinai J Med 1990 Sep;57(4):242-8. PMID: 2123297

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...